Reports for BAXTER CORPORATION
Company Name
BAXTER CORPORATION
Totals |
||
Shortage reports |
197 |
|
Actual shortage: | 7 (4%) | |
Anticipated shortage: | 1 (1%) | |
Avoided shortage: | 3 (2%) | |
Resolved: | 186 (94%) | |
Discontinuation Reports |
26 |
|
To be discontinued: | 0 (0%) | |
Discontinued: | 26 (100%) | |
Reversed: | 0 (0%) | |
Late reports |
11 (5%) |
|
Overdue reports |
0 (0%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Resolved | 2020-03-12 | 2020-04-08 | 108635 |
5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Resolved | 2021-12-06 | 2022-09-17 | 150508 |
5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Resolved | 2021-12-06 | 2022-09-02 | 150511 |
5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Resolved | 2021-12-06 | 2022-08-24 | 150514 |
5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Resolved | 2022-08-03 | 2022-09-02 | 165961 |
5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Resolved | 2022-08-03 | 2022-08-30 | 165965 |
5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Resolved | 2022-10-05 | 2022-10-26 | 171211 |
5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Resolved | 2022-10-05 | 2022-12-01 | 171215 |
5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Resolved | 2023-03-15 | 2023-03-31 | 187084 |
5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Resolved | 2023-04-12 | 2023-04-29 | 189362 |
5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Resolved | 2023-07-06 | 2023-07-31 | 197756 |
5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Resolved | 2023-10-11 | 2023-10-24 | 206816 |
5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Actual shortage | 2024-06-06 | 2024-06-08 | 229848 |
5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Actual shortage | 2024-06-06 | 2024-06-08 | 229851 |
0.4% LIDOCAINE HYDROCHLORIDE AND 5% DEXTROSE INJECTION | 50MG 4MG | SOLUTION | Resolved | 2019-10-04 | 2019-11-19 | 95574 |
0.4% LIDOCAINE HYDROCHLORIDE AND 5% DEXTROSE INJECTION | 50MG 4MG | SOLUTION | Resolved | 2019-12-19 | 2020-01-28 | 101629 |
HEPARIN SOD AND 0.9% SOD CHLORIDE INJ | 9MG 2UNIT | SOLUTION | Resolved | 2019-10-04 | 2020-01-07 | 95570 |
HEPARIN SOD AND 0.9% SOD CHLORIDE INJ | 9MG 2UNIT | SOLUTION | Resolved | 2020-01-28 | 2020-03-21 | 104484 |
HEPARIN SOD AND 0.9% SOD CHLORIDE INJ | 2UNIT 9MG | SOLUTION | Resolved | 2021-07-07 | 2021-09-22 | 141925 |
POTASS CHLOR 40MEQ 5% DEX AND 0.9% SOD CHLOR | 5G 300MG 900MG | SOLUTION | Resolved | 2017-05-04 | 2017-09-26 | 9057 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
0.9% SODIUM CHLORIDE INJECTION, USP | 900MG | SOLUTION | Discontinued | 2020-07-23 | 2020-07-23 | 120952 |
0.9% SODIUM CHLORIDE INJECTION, USP | 900MG | SOLUTION | Discontinued | 2020-07-23 | 2020-07-23 | 120955 |
5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Discontinued | 2020-07-23 | 2020-07-23 | 120958 |
5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Discontinued | 2020-07-23 | 2020-07-23 | 120961 |
POTASS CHLOR 40MEQ 5% DEX AND 0.9% SOD CHLOR | 5G 900MG 300MG | SOLUTION | Discontinued | 2020-11-26 | 2021-02-02 | 128947 |
CLINDAMYCIN INJECTION IN 5% DEXTROSE | 300MG | SOLUTION | Discontinued | 2023-02-06 | 2023-04-02 | 183710 |